Moreover, the Trump-weakened US dollar should aid reported earnings -- for multinational revenue generators like Merck. Not at all good for US tourists abroad, but a weak dollar benefits companies like Merck -- at the reported revenue line, but not the net profit line. Here's the latest projection from Wall Street:
. . .This quarter, analysts are expecting Merck’s revenue to decline 2.2% year on year to $15.75 billion [Ed. Note: but the net of currencies figures could be almost 2% better due to a weak dollar], a reversal from the 7.2% increase it recorded in the same quarter last year.
Adjusted earnings are expected to come in at $2.03 per share. . . .
Merck beat analysts’ revenue expectations by 1.6% last quarter, reporting revenues of $15.53 billion, down 1.6% year on year. It was a strong quarter for the company, with a solid beat of analysts’ constant currency revenue estimates and a decent beat of analysts’ EPS estimates. . . .
Me? I'm ready to get back home, even though 15 days of multi-stop vacation time has been. . . a blast! Onward, grinning.
नमस्ते
No comments:
Post a Comment